183 related articles for article (PubMed ID: 36227588)
61. Compliance With Screening Mammography Guidelines After a False-Positive Mammogram.
Hardesty LA; Lind KE; Gutierrez EJ
J Am Coll Radiol; 2016 Sep; 13(9):1032-8. PubMed ID: 27233908
[TBL] [Abstract][Full Text] [Related]
62. Screening mammography: experience in a health maintenance organization.
Hanchak NA; Kessler HB; MacPherson S; Xuan S; Solin LJ
Radiology; 1997 Nov; 205(2):441-5. PubMed ID: 9356626
[TBL] [Abstract][Full Text] [Related]
63. The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115).
Rosa DD; Bines J; Werutsky G; Barrios CH; Cronemberger E; Queiroz GS; de Lima VCC; Freitas-Júnior R; Couto JD; Emerenciano K; Resende H; Crocamo S; Reinert T; Van Eyil B; Nerón Y; Dybal V; Lazaretti N; de Cassia Costamilan R; de Andrade DAP; Mathias C; Vacaro GZ; Borges G; Morelle A; Caleffi M; Filho CS; Mano MS; Zaffaroni F; de Jesus RG; Simon SD
Breast Cancer Res Treat; 2020 Oct; 183(3):749-757. PubMed ID: 32728860
[TBL] [Abstract][Full Text] [Related]
64. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
[TBL] [Abstract][Full Text] [Related]
65. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening.
Taylor R; Boyages J
J Med Screen; 2001; 8(2):73-6. PubMed ID: 11480447
[TBL] [Abstract][Full Text] [Related]
66. Opportunistic breast cancer screening in Hong Kong; a revisit of the Kwong Wah Hospital experience.
Lui CY; Lam HS; Chan LK; Tam KF; Chan CM; Leung TY; Mak KL
Hong Kong Med J; 2007 Apr; 13(2):106-13. PubMed ID: 17406037
[TBL] [Abstract][Full Text] [Related]
67. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
68. Breast cancer screening practice and associated factors: Women's Health Survey in Uberaba MG Brazil, 2014.
Buranello MC; Meirelles MCCC; Walsh IAP; Pereira GA; Castro SS
Cien Saude Colet; 2018 Aug; 23(8):2661-2670. PubMed ID: 30137135
[TBL] [Abstract][Full Text] [Related]
69. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
[TBL] [Abstract][Full Text] [Related]
70. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
71. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.
Houssami N; Abraham LA; Miglioretti DL; Sickles EA; Kerlikowske K; Buist DS; Geller BM; Muss HB; Irwig L
JAMA; 2011 Feb; 305(8):790-9. PubMed ID: 21343578
[TBL] [Abstract][Full Text] [Related]
72. Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis.
Vale DB; Filho CC; Shinzato JY; Spreafico FS; Basu P; Zeferino LC
BMC Cancer; 2019 May; 19(1):432. PubMed ID: 31077162
[TBL] [Abstract][Full Text] [Related]
73. [Availability of mammographs in Mexico: Is it possible to expand coverage].
Sollozo-Dupont I; Galván-Espinoza HA; Villaseñor Y
Rev Med Inst Mex Seguro Soc; 2023 Nov; 61(6):736-746. PubMed ID: 37995285
[TBL] [Abstract][Full Text] [Related]
74. Mammography as a screening tool for peripheral vascular disease.
Dale PS; Graham J; Nichols KW; Catchings T; Richards M
Am J Surg; 2006 Oct; 192(4):488-91. PubMed ID: 16978956
[TBL] [Abstract][Full Text] [Related]
75. Mammographic screening for breast cancer in a resource-restricted environment.
Apffelstaedt SP; Dalmayer L; Baatjes K
S Afr Med J; 2014 Apr; 104(4):294-6. PubMed ID: 25118556
[TBL] [Abstract][Full Text] [Related]
76. Associated factors with mammographic changes in women undergoing breast cancer screening.
Sant'Ana RS; Mattos JS; Silva AS; Mello LM; Nunes AA
Einstein (Sao Paulo); 2016; 14(3):324-329. PubMed ID: 27759819
[TBL] [Abstract][Full Text] [Related]
77. Breast cancer screening preferences among hospitalized women.
Khaliq W; Visvanathan K; Landis R; Wright SM
J Womens Health (Larchmt); 2013 Jul; 22(7):637-42. PubMed ID: 23768020
[TBL] [Abstract][Full Text] [Related]
78. Mammography performance in Oman: Review of factors influencing cancer yield and positive predictive value.
Taif S; Tufail F; Alnuaimi AS
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e250-8. PubMed ID: 24673798
[TBL] [Abstract][Full Text] [Related]
79. Results of a pilot programme of mammographic breast cancer screening in the Western Cape.
Apffelstaedt JP; Hattingh R; Baatjes K; Wessels N
S Afr Med J; 2014 Apr; 104(4):297-8. PubMed ID: 25118557
[TBL] [Abstract][Full Text] [Related]
80. Trends in mammography 1991-96 and the impact of nationwide screening in The Netherlands.
van Leiden HA; van Gessel-Dabekaussen AA; van der Maas PJ; de Koning HJ
J Med Screen; 1999; 6(2):94-8. PubMed ID: 10444728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
